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Abstract
Inflammatory reactions are associated with sequestra-
tion of leukocytes in the lung. Complement activation
leads to accumulation of leukocytes in alveolar septa and
alveoli, to lung edema and hemorrhage. Although in
organs other than the lung leukocytes interact with the
vascular endothelium only in postcapillary venules, al-
veolar capillaries are considered to be the site of leuko-
cyte sequestration in the lung. However, pulmonary ven-
ules and arterioles have not been investigated systemati-
cally after complement activation so far. A closed thorac-
ic window was implanted in anesthetized rabbits; leuko-
cytes and red blood cells were stained, and the move-
ment of these cells was measured in superficial pulmo-
nary arterioles, venules and alveolar capillaries using flu-
orescence video microscopy before and 30 and 60 min
after infusion of cobra venom factor (CVF). Erythrocyte
velocity and macrohemodynamic conditions did not
change after CVF infusion and were not different from
the sham-treated controls. The number of sticking leuko-
cytes increased significantly compared to baseline and
control: by 150% in arterioles and in venules and by
740% in alveolar capillaries within 60 min after CVF infu-
sion. The width of alveolar septa in vivo was significantly
enlarged after CVF infusion, indicating interstitial pulmo-
nary edema. At the end of the experiments, myeloperox-
idase activity was higher in the CVF group, showing leu-
kocyte sequestration in the whole organ. It is concluded
that complement activation by CVF induces leukocyte
sequestration in lung arterioles, venules and alveolar
capillaries and leads to mild lung injury.
Introduction
Acute lung injury after activation of complement is of
clinical significance after extracorporeal circulation in
cardiac surgery [1]. Moreover, complement activation
and subsequent sequestration of leukocytes in the lung are
suggested as causative factors in the development of lung
injury, after ischemia and reperfusion or during sepsis [2,
3]. In a model of acute lung injury, complement activation
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by intravenous cobra venom factor (CVF) leads to seques-
tration of leukocytes in the lung and to lung edema and
hemorrhage within 30 min [4]. Leukocyte sequestration
as well as lung injury were inhibited in that model by pre-
treatment with monoclonal antibodies against leukocyte
and endothelial adhesion molecules [5, 6]. Histologically,
sequestered leukocytes were found mainly in alveolar cap-
illaries. Also, using intravital microscopy, leukocytes were
observed only in capillaries after intratracheal or pulmo-
nary arterial injection of complement-derived chemotac-
tic fragments [7, 8]. The most popular explanation for leu-
kocyte accumulation in capillaries is a discrepancy be-
tween cell and vessel diameter, which forces the leukocytes
to deform and delays their passage in capillaries [9–12].
However, leukocyte-endothelium interactions mediated
by adhesion molecules have been observed only in post-
capillary venules and not in capillaries in organs other than
the lungs [13]. This raises the question whether leukocyte-
endothelium interaction only in capillaries was the target
of antiadhesion therapy in the model of CVF-induced lung
injury, or whether adhesion in pulmonary venules was
inhibited. Indeed, we and others have recently shown that
leukocytes may also roll on and stick to the endothelium of
pulmonary postcapillary venules and precapillary arteri-
oles under physiological conditions as well as after pulmo-
nary ischemia and reperfusion [14–18]. Thus, leukocyte
adhesion in pulmonary venules may effectively play a sig-
nificant role in the development of lung injury. However,
with the exception of one study using leukocytes labeled in
vitro [7], the kinetics of leukocytes in pulmonary arterioles
and venules after complement activation have not been
investigated systematically so far, and primarily the role of
the pulmonary venules in the inflammatory process re-
mains unclear. Therefore, the purpose of the study was to
examine the microhemodynamics and the kinetics of leu-
kocytes labeled in vivo after systemic complement activa-
tion by intravital microscopy.
Methods
Experimental Setup
The experiment was designed to determine the time course and
the site of leukocyte sequestration after complement activation by
intravenous CVF. Microhemodynamics and the number of seques-
tered leukocytes were measured 30 min and 1 h after injection of
CVF in individual pulmonary arterioles, venules and alveolar capil-
lary networks. In parallel to this, macrohemodynamic parameters,
arterial blood gases and the width of alveolar septa were measured to
determine functional and morphological parameters of lung injury.
At the end of the experiments, the lungs were removed and myeloper-
oxidase (MPO) activity as indicator of the number of neutrophils
contained in the lungs was determined.
Animal Preparation
New Zealand White rabbits were used in this study. The animals
were anesthetized with thiopental sodium (50 mg i.v.) followed by
·-chloralose (50 mg/kg b.w.). Piritramide (0.5 mg/kg b.w.) was given
for analgesia and pancuronium bromide (0.3 mg/kg b.w.) for neuro-
muscular blockade. The rabbits were tracheotomized and ventilated
mechanically at an FiO2 of 0.3 and an inspiratory pressure of 8 mm
Hg. Catheters were introduced into the aorta for the measurement of
systemic arterial pressure, into the superior vena cava for measure-
ment of central venous pressure and into the pulmonary artery for
measurement of pulmonary artery pressure. A 5-Fr temperature
probe (Arrow, Erding, Germany) was inserted into the descendent
aorta to measure cardiac output after intravenous injection of 1 ml of
cold 0.9% sodium chloride solution by the thermodilution method.
For intravital microscopy, parts of the left third and fourth rib were
removed and a thoracic window was implanted as described pre-
viously [19]. The animals were placed in the right lateral position
under a fluorescence microscope (Leica, Wetzlar, Germany). To
visualize microvascular blood flow, FITC-labeled red blood cells
(Sigma, St. Louis, Mo., USA) were infused. Leukocytes were stained
in vivo by injection of rhodamine 6G (0.06 Ìmol/kg; Merck, Darm-
stadt, Germany). The green-light-emitting FITC-labeled red cells and
the red-light-emitting leukocytes were differentiated under the mi-
croscope by switching the emission and excitation filters (I2/3, L2
and N2 filter blocks; Leica, Wetzlar, Germany). The images were
recorded on video tape with a silicon-intensified target camera
(C 2400, Hamamatsu, Herrsching, Germany). Video recordings were
performed during inspiration periods prolonged to 5–10 s to avoid
respiratory movement. Prolongation of the inspiration period to
more than 15 s would lead to central venous congestion, bradycardia
and to a fall in blood pressure and cardiac output.
Microhemodynamics and Measurement of Leukocyte Kinetics
The measurements were performed offline using an image-pro-
cessing system (Optimas, Bioscan, Edmonds, Wash., USA), as de-
scribed in detail previously [17, 18]. Briefly, internal diameters of sub-
pleural arterioles and venules were measured as closest distance
between the vessel walls, visualized in green fluorescence image.
Mean red blood cell velocity was determined as harmonic mean of the
velocity of approximately 30 fluorescently labeled red cells passing a
predefined vessel cross-section. Sticking, i.e. non moving leukocytes
were determined as the number of fluorescent leukocytes not moving
for at least 5 s, which was the minimal length of a single observation
period during inspiration and long enough to differentiate between
rolling and adherent leukocytes. The numbers of sticking leukocytes
in arterioles and venules are normalized to the inner vessel surface of
the predefined vessel segment. For measurements of microhemody-
namics and leukocyte kinetics in alveolar capillaries, the subpleural
wall of single alveoli was investigated. The boundaries of the alveolar
wall were determined interactively using the image analysis system
and the alveolar wall area was measured. For measurement of red
blood cell velocity in alveolar capillaries, the transit of approximately
30 labeled red blood cells was followed, and the path and transit time
measured. The number of sticking leukocytes in the alveolar capillary
network of single alveoli was measured as the number of leukocytes
not moving for at least 5 s and normalized to the alveolar wall area. In
addition, the width of alveolar septa was measured as the mean of the
closest distance between the investigated alveolar wall area to the
adjacent alveoli. At least two arterioles, two venules and five alveolar
wall areas were investigated in each experimental phase.
MAP, mm Hg
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Table 1. Macrohemodynamics and blood gas analysis
Baseline
CVF control
30 min
CVF control
1 h
CVF control
90.7B2.9 86.9B3.9 83.0B3.01 81.8B1.3 81.5B4.9 78.0B2.3
CVP, mm Hg 3.1B1.6 3.1B0.6 4.7B1.4 4.2B0.9 5.3B1.4 4.0B0.8
PAP, mm Hg 15.6B2.6 12.0B1.2 18.9B4.1 13.0B1.2 16.4B2.8 14.7B2.9
CO, ml/min 408B212 269B30 354B232 280B29 373B222, 3 265B30
PaCO2, mm Hg 48.0B6.1 38.6B2.0 54.5B6.6 43.0B2.9 61.5B11.4 44.2B3.0
PaO2, mm Hg 152.7B12.5 148.7B4.4 127.4B11.7 148.6B4.0 131.1B19.1 149.1B3.5
Values are means B SEM; CVF (n = 8), control (n = 8).
1 p ! 0.005 vs. baseline.
2 n = 5 due to technical problems.
3 p ! 0.05 CVF vs. control.
MAP = Systemic arterial pressure; CVP = central venous pressure; PAP = pulmonary artery pressure; CO =
cardiac output; PaCO2 = arterial CO2 pressure; PaO2 = arterial O2 pressure.
Experimental Protocol
After the preparation period, the FITC-labeled red blood cells
were reinjected and the animal was placed under the microscope.
After a stabilization period of 15 min, the animals were randomly
assigned to the CVF or the control group. For leukocyte staining rho-
damine 6G was injected. Then baseline video recordings of 2 arteri-
oles, 2 venules and 5 alveolar wall areas were performed, macrohe-
modynamic parameters recorded and blood for arterial gas analyses
taken. The animals then received 0.2 mg/kg b.w. i.v. purified CVF
(kindly provided by D. White, Cambridge, UK) into the central
venous catheter or the same volume of saline. Thirty minutes and 1 h
after injection, video recordings of the same vessels and alveolar
areas were performed, macrohemodynamic parameters measured
and probes for blood gas analysis taken. At the end of the experi-
ments, the animals were sacrificed and the lungs removed for mea-
surement of MPO activity as described earlier in detail [20].
Statistics
All data are given as mean B standard error of the mean.
Repeated measurements were tested using the ANOVA for repeated
measurements followed by post hoc comparisons (Newman-Keuls
test) if significant differences were detected. Comparisons between
control and the CVF group were tested using the t test. Statistical
significance was assumed for p ! 0.05. Calculations were performed
using the computer program STATISTICA (StatSoft, Inc 1997, Tul-
sa, Okla., USA).
Results
Macrohemodynamic Parameters and Blood Gas
Measurements
Table 1 summarizes the results of macrohemodynamic
and blood gas measurements. In the CVF group, mean
arterial pressure was lower 30 min after CVF as compared
to baseline, and cardiac output was significantly higher
60 min after CVF as compared to control. Other macrohe-
modynamic and blood gas parameters were not signifi-
cantly different between groups. At 30 min after injection
of CVF, the white blood cell count had fallen significantly
from 5.0 B 0.6 W 106 cells/liter at baseline to 2.9 B 0.2 W 106
and 2.0 B 0.3 W 106 cells/liter at 30 min and 1 h after CVF
(p ! 0.0005 and p ! 0.01). The values at 30 min and 1 h
were significantly lower than in controls (5.7 B 0.6 W 106,
5.5 B 0.5 W 106 and 4.6 B 1.0 W 106 cells/liter) at baseline,
30 and 60 min (p ! 0.0005 and p ! 0.05 CVF vs. control at
30 and 60 min). Among leukocytes, the rate of neutrophils
fell from 28 B 3% at baseline to 7 B 2% 30 min after
injection of CVF.
Microhemodynamic Parameters and Leukocyte
Kinetics
For microscopic measurements, arterioles and venules
with a diameter of 20–30 Ìm were investigated. There was
no significant difference at baseline between CVF group
(arterioles 20.7 B 0.9 Ìm, venules 23.3 B 1.4 Ìm) and
control group (arterioles 21.3 B 1.0 Ìm, venules 20.5 B 1.2
Ìm). During the experiments, diameters did not change
significantly in the CVF group nor in the control group.
Under baseline conditions, mean red blood cell veloci-
ty was significantly lower in arterioles than in venules
(control: arterioles 1,507 B 101 Ìm/s, venules 1,860 B
117 Ìm/s; p ! 0.05; CVF: arterioles 1,309 B 164 Ìm/s,
venules 1,808 B 138 Ìm/s; p ! 0.05). These data confirm
our previous findings [14, 16, 17–19] and are explained
292 J Vasc Res 1999;36:289–298 Kuhnle/Kiefmann/Sckell/Kuebler/Groh/
Goetz
Fig. 1. Mean RBC velocity in pulmonary arterioles (a), venules (b) and alveolar capillaries (c). Values are means B
SEM; CVF (n = 8), control (n = 8); n.s.
by hydrodynamic forces in pulmonary microvessels un-
der zone 2 conditions [21]. In alveolar capillaries, mean
red blood cell velocity was markedly lower (control: 527
B 29 Ìm/s; CVF: 482 B 45 Ìm/s). There was no signifi-
cant difference between control and CVF group at base-
line, neither in arterioles or venules nor in alveolar capil-
laries. After treatment, mean red blood cell velocity did
not change significantly after CVF nor in the control
group (fig. 1).
Figure 2 shows the results of measurements of leuko-
cyte kinetics. Despite a higher red blood cell velocity, the
number of sticking leukocytes was higher in venules than
in arterioles. There was no difference between CVF and
control group at baseline. Thirty minutes after injection of
CVF or saline there was a 50% increase in the number of
sticking leukocytes in arterioles, a 100% increase in ven-
ules and a 500% increase in alveolar capillaries. After 1 h,
there was a further increase in the number of sticking leu-
kocytes measured in arterioles, venules and alveolar capil-
laries.
In figure 3, the changes in the width of alveolar septa
are shown. At baseline, alveolar septa were on average
17.1 B 1.1 Ìm in the control and 16.5 B 0.3 Ìm in the
CVF group. During the experiment, a significant increase
in the width of alveolar septa was noted in the CVF group
at 30 min and at 1 h, whereas the width of alveolar septa
in the control group remained unchanged.
At the end of the experiments, the lungs were removed
and the MPO activity was measured in both groups. Fig-
ure 4 shows the MPO activity of the right and left lung
lobe in the control and the CVF group. There was no sig-
nificant difference between left and right lungs; however,
MPO activity in the CVF group was more than double
that in the control group.
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Fig. 2. Sticking leukocytes in pulmonary arterioles (a), venules (b) and alveolar capillaries (c). Values are means B
SEM; CVF (n = 8), control (n = 8); * p ! 0.05 CVF vs. control; # p ! 0.05 vs. baseline.
Fig. 3. Width of alveolar septa. Values are
means B SEM; CVF (n = 8), control (n = 8);
* p ! 0.05 CVF vs. control; # p ! 0.05 vs.
baseline.
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Fig. 4. Activity of MPO in the lung. Values are means B SEM; CVF
(n = 8), control (n = 8); * p ! 0.05 CVF vs. control.
Discussion
Leukocytes play a decisive role in the pathogenesis of
acute inflammation in many tissues, including the lungs.
The early state of acute pulmonary injury is often charac-
terized by large numbers of neutrophils residing in the
vascular, interstitial and intra-alveolar spaces of the lungs
[22, 23]. These cells are thought not only to provide a host
defense function but, unfortunately, they can also injure
lung tissue by the release of toxic products including pro-
teases and reactive oxygen species. It has been shown in
various models that inhibition of leukocyte function or
leukocyte adhesion prevents lung injury. However, the
mechanisms by which blocking of leukocyte adhesion pre-
vents lung injury are less clear.
In the systemic microcirculation neutrophils adhere to
the walls of postcapillary venules and subsequently mi-
grate into the tissue at this site [13]. Inhibition of leuko-
cyte rolling or leukocyte sticking to the venular wall inter-
rupts this sequence and prevents subsequent migration of
the activated leukocytes and therefore injury [24, 25].
It has been suggested that the alveolar capillaries are
the site of leukocyte interaction with the microvasculature
in the lungs [7, 12, 26, 27]. The mechanisms involved in
leukocyte sequestration in the capillaries include the bio-
physical properties of leukocytes, especially the size of the
cell and the deformability along with the cross-section of
the capillaries and the hydrodynamic forces in the capil-
laries. Previous studies have shown that neutrophils with
diameters of approximately 6.4 Ìm have to change their
shape in order to pass through the alveolar capillaries with
distinctly smaller diameters (6.0 Ìm). This results in a
prolonged capillary transit time of the cells compared to
red cells [28]. Since leukocyte deformability strongly de-
pends on cell activation, i.e. the neutrophils become stiff-
er when activated, prolonged transit times of leukocytes
during their passage through the alveolar capillaries or
plugging of the cell within the capillary would be the result
[11, 29]. If these activated leukocytes, stagnant in the cap-
illary, come into direct contact with the endothelium or
interstitial fibroblasts – and there is evidence that they do
so [30] –, migration of the neutrophils into the interstitial
space of the lungs or into the alveolar space would be pos-
sible without involvement of any adhesion molecules.
However, it has been shown that blocking of adhesion
molecules inhibits leukocyte sequestration in the lungs
and prevents lung injury. This raises the question whether
leukocyte adhesion does occur in pulmonary venules and/
or arterioles, or whether adhesion molecules are involved
in leukocyte sequestration in the capillaries.
Our study provides quantitative information describ-
ing the microhemodynamics, kinetics and location of leu-
kocyte sequestration and the development of interstitial
lung edema, occurring after complement activation by a
bolus injection of cobra venom factor. In parallel to the
decrease in the number of circulating neutrophils in
arterial blood counts, leukocytes were sequestered in all
parts of the pulmonary microcirculation. Quantitatively,
most leukocytes were sequestered in alveolar capillaries,
but it has been shown that leukocytes also adhere to the
endothelium of pulmonary venules and arterioles after
systemic complement activation.
Despite higher red blood cell velocities in venules as
compared to arterioles, leukocyte adhesion was more pro-
nounced in venules. A different distribution of endothe-
lial adhesion molecules in arterioles and venules may
account for this finding [18]. The observation of higher
red blood cell velocities in venules as compared to arteri-
oles can be explained by the dependence of blood flow on
gravity and alveolar pressure in the lung, as described by
West et al. [31], and by the hydrodynamics in collapsible
vessels, as described by Permutt et al. [21]. During inspi-
ration, the field of observation in the lung is under the
condition of zone 2, i.e. alveolar pressure is higher than
the pressure in the venules and the venular part of the
capillary network. Some capillaries collapse, regional
blood flow decreases, resulting in a ‘vascular waterfall’,
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with low or even negative transmural pressure in the
venular compartment. As a result, the vessel cross-section
decreases, the blood flow velocity increases and may be
higher than in arterioles. In addition, a shift of blood from
the capillary to the venular compartment during inspira-
tion may increase flow and velocity in the venules.
Leukocyte retention was quantified by identifying and
measuring leukocytes not moving for at least 5 s. A 5-
second period is long enough to differentiate between roll-
ing mediated by selectin adhesion molecules where leuko-
cytes travel at velocities of 50–200 Ìm/s and remain sta-
tionary for not more than 0.06 s and sticking mediated by
integrin adhesion molecules. In alveolar capillaries, tem-
porarily arrested leukocytes stop at distinct sites of the
alveolar capillary networks usually for less than 1 s,
whereas another population of cells is retained by a differ-
ent mechanism for longer periods of time [18]. Previous
experiments have shown that inhibition of selectin-me-
diated adhesion results in a large reduction of leukocyte
rolling in pulmonary arterioles and venules as well as in a
reduction of the temporary arrest in alveolar capillaries,
but has no effect on sticking as quantified according to the
5-second criterion [16]. However, it has been reported
that temporary adherence may occur in venules of the sys-
temic circulation for variable periods of time ranging
between 1 and more than 60 s [32]. Therefore, the criteria
used to identify an adherent leukocyte differ among labo-
ratories, with stationary state ranging between 1 and 60 s
[13]. To determine the upper time range of leukocyte
adhesion, we measured leukocyte retention in 2 control
animals, within two subsequent observation periods pro-
longed to 45 s. Observations were separated by a 30-sec-
ond recovery period. In each animal 2 arterioles, 2 ven-
ules and 4 alveolar capillary networks were measured. At
the end of prolonged inspirations, the blood pressure was
reduced by 15% and the heart rate by 30%, an effect that
is explained by venous congestion due to a ‘Valsalva’- like
maneuver. Microcopically, red blood cell velocity de-
creased slightly as well. In arterioles (n = 4 observations),
venules (n = 4) and alveolar capillary networks (n = 4), 97,
98 and 100% of leukocytes, sticking for the first 5 s,
remained stationary until the end of the observation (30–
55 s). Except in 1 arteriole and 1 venule where a difference
of 1 leukocyte occurred, the number of sticking leukocytes
in the vessel or alveolar network were identical for the two
subsequent observation periods. These data indicate that
leukocytes classified as stickers according to a 5-second
criterion represent cells adherent for longer periods of
time.
Concomitant to leukocyte sequestration after injection
of CVF, alveolar septa, measured microscopically, were
enlarged and gas exchange was slightly reduced. However,
microhemodynamic conditions in pulmonary microves-
sels and macrohemodynamics were not significantly al-
tered. At the end of the experiments, the lungs showed an
increase of MPO activity.
The effects of complement activation on lung injury
have been studied by different groups previously. Web-
ster et al. [33], and Larsen et al. [34] have shown that
CVF, fragments of the activated complement factor C5
(C5f) or zymosan-activated plasma (ZAP) administered
intravascularly to rabbits caused acute neutropenia along
with sequestration of neutrophils within the pulmonary
vasculature. However, CVF or C5f alone did not induce
lung injury, as determined by extravasation of radioactive
labeled albumin. When combining CVF with an episode
of hypoxia, a significant increase of radioactively labeled
albumin in the lavage fluid and a decrease in PaO2
occurred and neutrophils were observed in the air spaces
histologically [34]. Doerschuk et al. [35] have shown that
infusion of ZAP in rabbits results in rapid sequestration
of radiolabeled neutrophils in the lungs if leukocytes were
injected intravenously or into the systemic microvascula-
ture after intra-arterial infusion of the cells. In a subse-
quent study, they showed that neutrophil sequestration
after ZAP infusion was due to a rapid decrease in PMN
deformability induced by a redistribution of actin from
the central to the submembrane regions of the neutrophils
[9]. A mild epithelial and endothelial injury was verified
by the clearance of intratracheally administered fluoresce-
in dextran and by the accumulation of colloidal carbon in
the pulmonary microvasculature after the same stimulus.
This injury could be prevented by depleting the animals
of PMN or by pretreatment with indomethacin [36]. Pre-
treatment of the rabbits with anti-CD18 monoclonal anti-
body showed that the initial accumulation of neutrophils
in the lungs could not be prevented, but the accumulation
of neutrophils was largely inhibited after 15 min of ZAP
infusion [37]. In the rat, complement activation by intra-
venous CVF results in acute lung injury, as reflected by an
increase in pulmonary microvascular permeability, as
well as by morphological evidence of damage to the pul-
monary vascular endothelium [38]. This injury is depen-
dent on neutrophils and toxic oxygen metabolites [38].
Permeability changes and hemorrhage in that model were
reduced by pretreatment with antibodies directed against
adhesion molecules CD18 [6], CD11a, CD11b, ICAM1
[39], P-selectin [40] and L-selectin [41]. Interestingly, if
CVF was injected in P-selectin-, ICAM-1- or P-selectin/
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ICAM1-deficient mice, mutant mice did not show a
reduction in neutrophil sequestration or lung injury in
contrast to wild-type mice treated with the respective
antibodies [42].
Our data confirm findings that complement activation
leads to an accumulation of leukocytes in the lungs and to
mild lung injury. There is strong evidence that all stimuli,
infusion of ZAP, CVF or C5f, activate circulating leuko-
cytes, thus reducing their deformability and resulting in
accumulation of the cells in pulmonary capillaries. How-
ever, none of these studies answered the question whether
activation of complement leads to adhesion of leukocytes
in extracapillary vessels, especially in postcapillary ven-
ules, as it would be expected in microvascular beds in the
systemic circulation. In the only study that directly inves-
tigated leukocyte kinetics during acute inflammation, se-
questration of neutrophils was found almost exclusively
in capillaries [7], where the transit of leukocytes labeled in
vitro was microscopically investigated in a microscopic
field containing an arteriole, a venule and the connecting
capillary network after administration of C5f into either
the airways or the pulmonary arteries of anesthetized
dogs. Concerning the absence of leukocyte adhesion in
arterioles and venules, their findings differ from ours.
Besides possible differences between species or the stimu-
lus used, the major difference between our studies is the
labeling technique of leukocytes. Lien et al. [7] used neu-
trophils that had been separated by plasma-Percoll gra-
dients in vitro. Since in vitro separation of leukocytes may
induce activation and therefore shedding of L-selectin
adhesion molecules, these cells might lose their ability to
interact with the vascular endothelium of venules and
arterioles [16–18, 43, 44]. In a subsequent study, Downey
et al. [28] employed morphometric techniques after local
instillation of C5f in rabbit lungs. They again found neu-
trophil sequestration predominantly in the capillaries of
the interalveolar septa. The number of neutrophils se-
questered in the capillary bed per unit surface area of bas-
al lamina they found was 10-fold higher than the number
sequestered in the arteriolar or venular compartment.
Considering that the surface area of the capillary bed
exceeds the surface of the venular or arteriolar compart-
ment by far, they concluded that migration from extra-
capillary vessels must be negligible. It seems very difficult
to compare the morphometric data of the latter study with
our quantitative in vivo microscopic data. It has to be
noted that these authors found leukocytes within the
venular and arteriolar compartment. However, the mean
diameter of the venules and arterioles analyzed in that
study is not documented. Since vessel diameters were pos-
sibly underestimated in histologic sections after intratra-
cheal fixation of the lungs, it cannot be excluded that ves-
sels classified as arterioles and venules represent small
arteries and venules with an in vivo diameter of larger
than 50–100 Ìm. Each arteriole or venule with 100 Ìm in
diameter (4th or 5th vessel order) supplies approximately
150 terminal vessels with diameters of 20 Ìm [45] (which
can hardly be differentiated from a capillary in a histo-
logic section). Therefore, it may be speculated whether
Downey et al. [26] underestimated the number of post-
capillary venules and precapillary arterioles including the
neutrophils within these vessels in favor of the capillary
compartment.
Intravital microscopic studies in skeletal muscle of
hamsters or in mesenteric vessels have shown that leuko-
cyte recruitment to sites of injury follows three steps, all
mediated at least in part by adhesion molecules. First, leu-
kocytes roll along the endothelium, a phenomenon depen-
dent on L-selectin, an adhesion molecule expressed on the
surface of leukocytes and P-selectin which is expressed on
endothelial cells after stimulation. Second, leukocytes
firmly adhere to the endothelial cells, a phenomenon
involving ß2 integrins (CD18/CD11) and ICAM1 adhe-
sion molecules. Third, the leukocytes extravasate if there
is a chemotactic gradient to the tissue. However, these
mechanisms have been described almost exclusively in
postcapillary venules, under special circumstances in ar-
terioles, but not in capillaries [13, 44].
Our finding of leukocyte sticking in venules and arteri-
oles support the possibility that the same mechanisms
may be valid also in the lungs. The protective effect of
anti-adhesion therapy in different models of lung injury
may be explained by inhibiting leukocyte-endothelium
interactions in venules and possibly arterioles. Neverthe-
less, the situation may be more complex. A very dense
network of alveolar capillaries, with diameters below the
diameter of leukocytes, promotes retention of leukocytes
even under physiological conditions. Activation of leuko-
cytes leads to stiffening of the cells. Decreased leukocyte
deformability, together with swelling of endothelial cells,
further promotes leukocyte retention in the lung capillar-
ies during inflammation. Doerschuk et al. [37] have pos-
tulated that this is the initial, CD18-independent mecha-
nism of leukocyte sequestration, whereas the following
step, firm adhesion and extravasation, is CD18 depen-
dent [37]. In addition, there is increasing evidence that
adhesion molecules are involved in leukocyte adhesion,
also in capillaries. Recently, we were able to show that
inhibition of the selectin adhesion molecules by fucoidin
reduces leukocyte rolling in pulmonary arterioles and
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venules and leukocyte endothelial interactions in alveolar
capillaries [16].
In summary there is strong evidence that most of all
activated leukocytes after a chemotactic stimulus were
sequestered in alveolar capillaries. A presumably smaller
fraction of leukocytes roll and stick to the endothelium of
pulmonary arterioles and venules. Since inhibition of
adhesion molecules, i.e. selectins as well as integrins, pro-
tects the lungs fully or in part from injury, two mecha-
nisms are conceivable. Either adhesion molecules are
involved in the leukocyte-vascular interaction and emi-
gration in alveolar capillaries or leukocytes roll, stick and
emigrate predominantly from the pulmonary arteriolar or
venular site.
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